Dow Pharmaceuticals Inc
May 16, 2012 at 12:41 | Source: Moneycontrol.com
Apr 24, 2012 at 19:36 | Source: Reuters
Apr 19, 2012 at 14:22 | Source: Moneycontrol.com
Mar 13, 2012 at 14:54 | Source: Moneycontrol.com
Feb 16, 2012 at 10:56 | Source: Reuters
Videos »
Photos »
/ 
Related News »
Ampio Pharmaceuticals Inc. shares rose 10.16 percent ... Intrepid Potash Inc. (IPI): down 3.05 percent, or 61 cents, to $19.41. The Dow fell 33 points to close at 12,598. Nasdaq was off 19 points, ending at 2,874. The S&P 500 closed at 1,324 ...
May 16, 2012 at 20:32 | Source: The Business Journal
The S&P is trading fractionally lower to 1,320 and the Dow is trading 0.3% lower to 12,489. Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious ...
May 25, 2012 at 16:32 | Source: Financial News Network Online
DOW) , Valero Energy (NYSE:VLO) , Hartford Financial Services (NYSE:HIG) , Arena Pharmaceuticals (NASDAQ:ARNA) , CONSOL Energy (NYSE:CNX) , and Schlumberger (NYSE:SLB) . (Read full report by clicking the link below, you may need to copy and ...
May 16, 2012 at 12:39 | Source: Marketwatch
The stock has outperformed the Dow (5.2% to the Dow's 0.0%) and outperformed the S&P 500 (5.2% to the S&P's 0.1%) during today's trading. Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on the research ...
May 24, 2012 at 16:48 | Source: TMCnet
Mylan Inc. Mylan Inc. Latest from The Business Journals Moody's upgrades Mylan's credit rating Dow still at a loss but regains ... Tuesday that it had reached a settlement with Sunovion Pharmaceuticals over a patent lawsuit related to the ...
May 29, 2012 at 14:04 | Source: The Business Journal
FRANKFURT -(Dow Jones)- German chemical and pharmaceutical group Bayer AG (BAYN.XE) and Onyx Pharmaceuticals, Inc. (ONXX) Tuesday said a phase III trial of Nexavar treatment for lung cancer patients failed to meet its primary endpoint of ...
May 22, 2012 at 07:17 | Source: NASDAQ
NEW YORK (Dow Jones)--Shares of Arena Pharmaceuticals Inc. (ARNA) nearly doubled Friday, hitting their highest point in 20 months, after a panel of experts for the U.S. Food and Drug Administration recommended the company's obesity drug for approval.
May 11, 2012 at 16:06 | Source: Wall Street Journal
U.S. generic drug maker Mylan Inc settled a patent infringement suit with Sunovion Pharmaceuticals Inc ... casting doubt on the outlook for tech spending. * The Dow Jones industrial average was up 33.60 points, or 0.27 percent, at 12,529.75.
May 25, 2012 at 08:33 | Source: Reuters
The Dow is down 0.2% to 12,469 and the S&P is currently down 0.3% to 1,315. Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such ...
May 24, 2012 at 16:33 | Source: Financial News Network Online
The Dow Jones Industrial Average is now trading 0.7% higher ... has fallen 3% while the 200-day MA has risen 0.6%. Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other ...
May 25, 2012 at 18:41 | Source: Zacks.com